Inflarx Nv Stock Performance
| IFRX Stock | USD 2.36 0.05 2.16% |
On a scale of 0 to 100, InflaRx NV holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, InflaRx NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding InflaRx NV is expected to be smaller as well. Please check InflaRx NV's downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether InflaRx NV's current trending patterns will revert.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in InflaRx NV are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, InflaRx NV showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.16 | Five Day Return (9.92) | Year To Date Return 43.9 | Ten Year Return (84.27) | All Time Return (84.27) |
1 | InflaRx shares maintain Buy rating from H.C. Wainwright on Gohibic trial analysis - Investing.com | 09/26/2024 |
2 | InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update | 11/08/2024 |
3 | InflaRx Receives Positive CHMP Opinion for GOHIBIC for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome | 11/15/2024 |
4 | InflaRx Trading Up 3.8 percent - Heres Why - MarketBeat | 12/06/2024 |
| Begin Period Cash Flow | 16.3 M |
InflaRx |
InflaRx NV Relative Risk vs. Return Landscape
If you would invest 145.00 in InflaRx NV on September 16, 2024 and sell it today you would earn a total of 91.00 from holding InflaRx NV or generate 62.76% return on investment over 90 days. InflaRx NV is currently generating 0.8513% in daily expected returns and assumes 4.5667% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than InflaRx, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
InflaRx NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for InflaRx NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as InflaRx NV, and traders can use it to determine the average amount a InflaRx NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1864
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IFRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.85 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average InflaRx NV is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of InflaRx NV by adding it to a well-diversified portfolio.
InflaRx NV Fundamentals Growth
InflaRx Stock prices reflect investors' perceptions of the future prospects and financial health of InflaRx NV, and InflaRx NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on InflaRx Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 79.28 M | ||||
| Shares Outstanding | 58.88 M | ||||
| Price To Earning | (7.90) X | ||||
| Price To Book | 2.03 X | ||||
| Price To Sales | 1,317 X | ||||
| Revenue | 63.09 K | ||||
| EBITDA | (42.06 M) | ||||
| Net Income | (42.67 M) | ||||
| Cash And Equivalents | 23.68 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 1.12 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.93 X | ||||
| Book Value Per Share | 1.74 X | ||||
| Cash Flow From Operations | (37.81 M) | ||||
| Earnings Per Share | (1.03) X | ||||
| Market Capitalization | 138.96 M | ||||
| Total Asset | 120.21 M | ||||
| Retained Earnings | (286.13 M) | ||||
| Working Capital | 92.62 M | ||||
| Current Asset | 67.08 M | ||||
| Current Liabilities | 2.74 M | ||||
About InflaRx NV Performance
Evaluating InflaRx NV's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if InflaRx NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if InflaRx NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 7 K | 7.4 K | |
| Return On Tangible Assets | (0.36) | (0.37) | |
| Return On Capital Employed | (0.43) | (0.46) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | (0.42) | (0.44) |
Things to note about InflaRx NV performance evaluation
Checking the ongoing alerts about InflaRx NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for InflaRx NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| InflaRx NV appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| InflaRx NV has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Werewolf Therapeutics, Inc. Shares Sold by Point72 Asset Management L.P. |
- Analyzing InflaRx NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether InflaRx NV's stock is overvalued or undervalued compared to its peers.
- Examining InflaRx NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating InflaRx NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of InflaRx NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of InflaRx NV's stock. These opinions can provide insight into InflaRx NV's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.